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Leptin is a small peptide hormone that is mainly produced in adipose tissues. Leptin plays an 
important role in regulating appetite and energy expenditure and may be involved in modulating 
bone mineralization. This study was designed to test the association of serum leptin kidney 
function in renal transplant recipients. We studied 72 kidney transplanted recipients. In this 
study a significant difference of serum leptin between males and females with higher values in 
females was seen (p>0.05). There was not relationship between serum leptin with body mass 
index, age and creatinine clearance (p>0.05). A negative relationship between serum leptin and 
the duration of kidney transplantation was found (r= -0.26, p= 0.03). The clinical significance 
of inverse association between serum leptin and the duration of renal transplantation, should 
consider more in larger studies. 
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IntroductionRenal transplantation (RT) is a treatment of choice 
for patients with end-stage kidney diseases. Kidney 
transplantation corrects most of the metabolic disorders (1). Leptin is released from fat tissues and circulating levels 
of leptin have been shown to be positively associated with 
fat mass in both lean and obese individuals (1-3). Previous 
studies have shown elevated serum leptin levels in renal 
failure patients (2-4). Leptin level is increased before 
transplantation, and decreased in the first year of RT (2-6). Increase in serum leptin level may be seen thereafter 
and may be due to increase in fat mass, insulin resistance 
or steroid use in kidney transplant patients (4-8). Leptin 
first emerged as a component of a regulatory fat mass and 
energy expenditure but recent evidence showed that leptin 
might be a potential mediator of the protective effects of fat 
mass on bone tissues (7-9). 
Objectives
This study was designed to test the association of serum 
leptin kidney function in renal transplant recipients. 
Patients and Methods
Patients
This cross-sectional study was conducted on a group of 
stable kidney transplant patients, referred to the clinic of 
nephrology to continue their treatment. Exclusion criteria 
included presence of acute rejection, any active or chronic 
infection, taking antibiotics during the past two months, and 
taking medications such as non steroidal anti-inflammatory 
drugs. After admission, all patients were examined for body 
mass index. Patients' histories concerning the length of 
the time that they were undergone kidney transplantation 
and their treatments were also obtained. Body mass index 
(BMI) was calculated using the standard formula (weight in 
kilograms/height in square meters).
Laboratory methods
Serum leptin was measured as follows; blood samples were 
drawn after an overnight fasting, and centrifuged within 
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15 minutes of drawing. The levels were measured by an 
enzyme-linked immunosorbent assay (ELISA) method using 
DRG kit (DRG diagnostic, Berline, Germany). Serum leptin 
normal range for males was considered to be 3.84±1.79 
and for females 7.36±3.73 ng/mL. After an overnight 
fast peripheral venous blood samples were collected for 
biochemical analysis including serum creatinine, blood 
urea nitrogen using standard kits. Creatinine clearance was 
evaluated from serum creatinine, considering age and body 
weight (9).
Ethical issues 
(1) The research followed the tenets of the Declaration 
of Helsinki; (2) informed consent was obtained; (3) the 
research was approved by ethical committee of Shahrekord University of Medical Sciences.
Statistical Analysis
The results were expressed as the mean±SD and median 
values. A statistical correlation was assessed using a partial 
correlation test. Comparison between groups were done 
using student’s t-test. For normalization of leptin data, 
their second square were used. All statistical analyses were 
performed with the SPSS 11.5 (SPSS Inc., Chicago, USA). 
Statistical significance was determined at a p<0.05.
Results
A total of 72 patients were enrolled in this study, including 
47 men, 25 women, in whom, 11 patients had diabetes 
mellitus. The mean patients’ age was 44±12 years. The 
transplantation period was 67.5±42 months (median: 62 
years). The patients’ data are shown in Table 1. In this study 
there was a significant difference of serum leptin between 
females and males (p<0.001). There was no significant 
difference of serum leptin between diabetic and non-diabetic 
patients. In this study, there was an inverse association 
between serum leptin and duration of renal transplantation 
(r=-0.26, p=0.03). There was not any significant association 
between serum leptin and creatinine clearance, BMI or ages 
of the patients (p> 0.05). 
Discussion
In the current study we found a significant difference of 
serum leptin between females and males, while there was 
no significant difference of serum leptin between diabetic 
and non-diabetic patients. There was an inverse association 
between serum leptin and duration of renal transplantation. 
There were not any significant association between serum leptin and creatinine clearance or age of the patients. 
Souza et al. carried out a study on thirty-two RT patients 
and found no correlation between leptin and renal function 
in their study. They showed also that during the first post 
transplant year, serum leptin levels decreased significantly in relation to pre-transplant period (10).
Nicoletto et al. studied thirty-two kidney transplant 
recipients, who were followed up for 5 years after 
transplantation. They found leptin level decrease in the 
immediate post-transplant period and remain reduced for at least one year. Five years after transplantation, leptin have 
a profile similar to those in the pre-transplant period. They 
concluded that leptin profile is possibly associated with the 
elevated incidence of cardiovascular diseases observed in the late post-transplant period (11).
Conclusion
The clinical significance of inverse association between 
serum leptin and the duration of renal transplantation, 
should consider more in larger studies. 
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